![Erythego Gel,Brimonidine (5mg) 0.33%, Non prescription, Packaging Size: 15 ml at Rs 400/piece in Nagpur Erythego Gel,Brimonidine (5mg) 0.33%, Non prescription, Packaging Size: 15 ml at Rs 400/piece in Nagpur](http://5.imimg.com/data5/SELLER/Default/2023/4/301947224/OT/OT/LA/73733626/whatsapp-image-2023-04-04-at-20-16-31.jpeg)
Erythego Gel,Brimonidine (5mg) 0.33%, Non prescription, Packaging Size: 15 ml at Rs 400/piece in Nagpur
![Efficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies - JDDonline - Efficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies - JDDonline -](http://dl.jddonline.com/articleimages/article_2166/table4.png)
Efficacy and Safety of Once-Daily Topical Brimonidine Tartrate Gel 0.5% for the Treatment of Moderate to Severe Facial Erythema of Rosacea: Results of Two Randomized, Double-blind, and Vehicle-Controlled Pivotal Studies - JDDonline -
![Full article: Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits Full article: Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits](https://www.tandfonline.com/cms/asset/f1970196-a561-48fc-8605-b5d20905141b/iphd_a_1328693_f0005_b.jpg)
Full article: Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits
![Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology - Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology -](https://onlinelibrary.wiley.com/cms/asset/e34cc4b0-996a-4c89-8154-7af47ccf2e7f/jdv13305-fig-0005-m.jpg)
Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study - Layton - 2015 - Journal of the European Academy of Dermatology and Venereology -
![Before and after results of Brimonidine tartrate treatment for rosacea, a new medicated gel reduces redness and the appearance of blood vessels. Stock Photo | Adobe Stock Before and after results of Brimonidine tartrate treatment for rosacea, a new medicated gel reduces redness and the appearance of blood vessels. Stock Photo | Adobe Stock](https://as2.ftcdn.net/v2/jpg/02/87/65/85/1000_F_287658554_DlRWYmpXsG0aZ8vuZaTR95JWJQKfDT6H.jpg)